~~<i id='B59F805EA0'><strike id='B59F805EA0'><tt id='B59F805EA0'><pre id='B59F805EA0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：explore 2025-09-27 16:49:32 - browse：55

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Takeda, Janssen join wearable maker to measure scratching

focus

leisure time

entertainment

hotspot

focus

knowledge

Illustration:AlexHogan/STAT;Photo:EisaiviaAPSincetheFDA’sapprovaloflecanemab(marketedasLeqembi)andMe

WSS

With clinical trial data readouts, here's how to spot spin

UnitedHealth’s Optum accused of antitrust violations in California

BIO selects John Crowley as new CEO

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

SCOTUS to consider access to abortion pill mifepristone

Congenital heart disease patients face new threat of heart failure

knowledge

leisure time

focus

Moonlake's readout produced a cash windfall. Risks remain

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

What does generative AI mean for health care? We asked experts

What PEPFAR has meant on the ground in Ukraine

Trump demands the U.S. pay no more for drugs than other countries … again

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

DIEP, the 'gold standard' of breast reconstruction, is under threat

Diagnostic tests are hitting their mathematical limits

leisure time

Will the market for weight loss drugs really reach $100 billion?

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

What PEPFAR has meant on the ground in Ukraine

What causes an itch? Researchers may have solved the mystery

FDA investigates CAR

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

entertainment

hotspot

focus

knowledge